UK Markets closed

AstraZeneca CEO Soriot says to work with new chairman for many years

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
FILE PHOTO: Pascal Soriot, chief executive of AstraZeneca, attends an interview with Reuters in Shanghai
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

FRANKFURT (Reuters) - Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in 2023, for many years to come, suggesting he is not ready to retire.

The company said on Friday that Michel Demare will take over from outgoing Chairman Leif Johansson, who, like Soriot, has been in his leadership position for about a decade.

"Michel and I will be working together and forming an excellent team for the many years to come," Soriot said on an analyst call after the company released its quarterly results.

(Reporting by Ludwig Burger and Natalie Grover; editing by Jason Neely)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting